Upcoming Wyeth v. Levine Case to Affect Pharmaceutical Litigation

The Supreme Court’s upcoming decision in Wyeth v. Levine is expected to have widely felt consequences for those seeking to recover damages from pharmaceutical companies. The drug industry argues that the federal regulation should pre-empt lawsuits claiming that pharmaceutical companies sold defective or unsafe drugs. Consumer advocates and others, including the New England Journal of Medicine, contend that such pre-emption would drastically reduce the safety of prescription drugs.

If this case is a victory for the drug companies, it will severely limit the consumer’s and patient’s right to hold drug companies accountable for wrongdoing, incluidng rushing dangerous drugs to the market without gathering the necessary facts to warn patients of hazards and risks of taking the drug.

I will keep this blog updated with information on Wyeth.

For more information on our pharamceutical litigation, click HERE.

If you believe you have been injured from taking a prescription drug, including Chantix, Digitek, Byetta or Trasylol, please contact Ed Wallis today at (901) 527-2125, or send Ed an e-mail by clicking HERE.